LivaNova (LIVN) Net Margin Growth (3y) (2019 - 2026)
LivaNova (LIVN) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 300.00 |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 2,742.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,742.00 |
| Mar 31, 2026 | 358.00 |
| Dec 31, 2025 | 795.00 |
| Sep 30, 2025 | 5,001.00 |
| Jun 30, 2025 | 122.00 |
| Mar 31, 2025 | -10,456.00 |
| Dec 31, 2023 | 546.00 |
| Mar 31, 2023 | 322.00 |
| Dec 31, 2022 | 55.00 |
| Jun 30, 2022 | 642.00 |
| Dec 31, 2020 | 2,864.00 |
| Mar 31, 2020 | 45.00 |
| Dec 31, 2019 | 948.00 |
| Jun 30, 2019 | 157.00 |